ZAI LAB

09688

Current ValuationThe current P/E ratio is -14.89, within the reasonable range, cheaper than 79.28% of the time in the past 3 years, and the industry ranks 56/78, the industry Median -5.11.

-14.89xP/E
Stock priceHK$19.31Earnings per shareHK$-1.30

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0155310465620

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09926HKAKESO
-88.68x77.35%HK$98.75B
09688HKZAI LAB
-14.89x378.99%HK$21.97B
01877HKJUNSHI BIO
-38.47x85.33%HK$17.80B
09606HKDUALITYBIO-B
-9.90x85.58%HK$16.40B
07666HKMETIS TECHBIO-P
-38.50x96.70%HK$15.67B
02627HKAB&B BIO-TECH-B
-46.87x--HK$11.54B
01952HKEVEREST MED
-182.71x324.61%HK$11.34B
06855HKASCENTAGE
-6.63x18.68%HK$11.20B
02595HKGENFLEET-B
-6.97x78.32%HK$10.57B
06938HKRIBOLIFE-B
-47.36x29.88%HK$9.25B
02493HKMABWELL-B
-8.42x--HK$9.11B
09887HKLEADS BIOLABS-B
-29.52x8.67%HK$9.07B
02616HKCSTONE PHARMA-B
-16.54x1.72%HK$7.98B
02335HKMICOT PHARMA-B
-17.31x37.50%HK$7.27B
01672HKASCLETIS-B
-10.57x78.59%HK$7.20B
09966HKALPHAMAB-B
-34.25x--HK$6.94B
02171HKCARSGEN-B
-67.02x51.12%HK$6.88B
01779HKLONGBIO-B
-27.38x--HK$6.82B
02256HKABBISKO-B
-10.27x300.95%HK$5.52B
06872HKTENNOR THERAP-B
-33.54x--HK$5.38B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.